 superDimension, an Mi3 portfolio company, enables minimally-invasive detection of lung desease. |
 Mi3 Venture Partners invests in early-stage companies developing life technologies. Our portfolio companies generally use engineering principles or the physical sciences to leverage novel developments in biology into products that address critical unmet clinical needs. We seek opportunities to partner with management teams seeking financial, human and strategic resources to create valuable products from breakthrough discoveries in biology. Combining decades of venture capital, operating and strategy consulting experience, our team understands the unique challenges facing growing companies in the healthcare industry. We take a long-term, collaborative approach to working with entrepreneurs, providing not only capital but also hands-on support and access to a broad network of resources. We are seeking creative entrepreneurs with technologies that fit our investment criteria. |